| Clinical significance: |
hsa_circ_0004771 showed diagnostic potential for distinguishing CRC patients from healthy controls, with AUC of 0.784, sensitivity of 84%, and specificity of 64%; combined with hsa_circ_0019120, AUC was 0.8348 with sensitivity of 84% and specificity of 80%. |
| Description: |
Platelet-derived hsa_circ_0004771 was upregulated in CRC and advanced polyp patients, with statistically significant upregulation in CRC compared with healthy controls. The study supports its potential clinical utility as a non-invasive biomarker for CRC risk assessment and early detection, especially when combined with hsa_circ_0019120. |